Comparative study between effect of niclosamide and vitamin c on methotrexate-induced liver injury in mice
ZS Zeki, AI Al-Gareeb - Mustansiriya Medical Journal, 2021 - journals.lww.com
Background: Niclosamide is an old drug used before in the treatment of tapeworms, its main
mechanism of action is through the amelioration of mitochondrial-free radical generation. It …
mechanism of action is through the amelioration of mitochondrial-free radical generation. It …
Mitochondrial-triggered immune responses mechanistically connect drug-induced steatohepatitis and cardiomyopathy associated with nonalcoholic steatohepatitis
H Wang, S Pai, S Ishiyama, X Guo, WD Gao… - Cellular & Molecular …, 2021 - nature.com
In our prior publication [1], we elucidated IL-33-dependent mechanisms that regulate drug-
induced liver injury. In this commentary, we mechanistically connected IL-33-dependent …
induced liver injury. In this commentary, we mechanistically connected IL-33-dependent …
Radiothérapie stéréotaxique hépatique: particularités cliniques et implications techniques, résultats. Quelle machine pour quelle situation?
O Riou, S Valdenaire, P Debuire, P Fenoglietto… - Cancer …, 2019 - Elsevier
Résumé La radiothérapie stéréotaxique hépatique est une technique de traitement en
développement pour le traitement des tumeurs primitives et secondaires. Sa mise en œuvre …
développement pour le traitement des tumeurs primitives et secondaires. Sa mise en œuvre …
Épidémiologie de la stéato-hépatite non alcoolique. Étendue du problème et son impact sur la santé publique
A Vallet-Pichard, L Parlati, S Pol - La Presse Médicale, 2019 - Elsevier
Résumé La maladie du foie gras non alcoolique (NAFLD) est la plus commune des
hépatopathies, la cause la plus fréquente de perturbations chroniques du bilan hépatique et …
hépatopathies, la cause la plus fréquente de perturbations chroniques du bilan hépatique et …
[PDF][PDF] Editorial. Drug-induced hepatotoxicity
FP Busardò, A Grieco - Eur Rev Med Pharmacol Sci, 2017 - europeanreview.org
Paracetamol is the most commonly used antipyretic and pain reliever. Paracetamol
overdoses are the leading cause of acute poisoning in the United States and represent …
overdoses are the leading cause of acute poisoning in the United States and represent …
[引用][C] Modern aspects of Hepatology: liver steatosis and fibrosis through the prism of Comorbidity in Pediatric Practice
The use of computer technologies at the preclinical stage of hepatotoxicity assessment of antiviral drug riamilovir
KD Fedulova, NV Izmozherova… - AIP Conference …, 2020 - pubs.aip.org
Despite the fact that riamilovir is already used in clinical practice for influenza treatment in
the territory of the Russian Federation, it can be used as broad-spectrum potential antiviral …
the territory of the Russian Federation, it can be used as broad-spectrum potential antiviral …
Methylseleninic acid and grape seed extract alleviate tamoxifen induce hepatotoxicity in rats
NMA Hassanein, AAF Ali… - … and environmental health …, 2018 - Springer
Objective The current study aimed to evaluate the hepatoprotective potential of
methylseleninic acid (MSA) and grape seed extract on tamoxifen-induce hepatotoxicity in …
methylseleninic acid (MSA) and grape seed extract on tamoxifen-induce hepatotoxicity in …
Efeitos Nutricionais e Mecanismos Bioquímicos na Doença Hepática Gordurosa Não Alcoólica
W Malagó-Jr, AMM Rubiatti… - Revista da …, 2021 - rasbran.emnuvens.com.br
A Doença Hepática Gordurosa Não Alcoólica (DHGNA) tem ganhado proporções
alarmantes, afetando de 25 a 30% da população mundial. Sua ocorrência está associada …
alarmantes, afetando de 25 a 30% da população mundial. Sua ocorrência está associada …
Evaluation of the effects of TAK-242 and GIT-27 on methotrexate-induced liver injury
BI Mohammad, BS Ahmed… - Mustansiriya Medical …, 2018 - journals.lww.com
Background: Methotrexate (MTX)-induced liver injury is a common problem that is described
as increased level of hepatic biomarkers that is seen in 14%–25% of patients with …
as increased level of hepatic biomarkers that is seen in 14%–25% of patients with …